Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy Clinical Trials in Shanghai, Shanghai Municipality

A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma